euro adhoc: Semperit AG Holding
Financial Figures/Balance Sheet
Semperit:
1st to 3rd quarter results 2008
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
9-month report
21.11.2008
. Revenue rose by 8.1% to EUR 492.0 million . EBIT improved by 1.4% to EUR 47.0 million
The perceptible slowdown in the world economy and the ongoing significant price rises on global raw material markets have led to a considerable deterioration of the conditions under which Semperit operates. Despite this difficult business environment, Semperit once again succeeded in increasing total revenue. Earnings were negatively affected, in particular by the high costs of raw materials, in the third quarter.
| |1-9/2007 |1-9/2008 |Change in % | |Revenue in EUR million |455.1 |492.0 |+8.1 | |EBIT in EUR million |46.4 |47.0 |+1.4 | |EBT in EUR million |41.3 |46.2 |+12.0 | |Net profit for the period in EUR|29.9 |31.4 |+5.1 | |million | | | |
In the first three quarters of 2008, total revenue amounted to EUR 492.0 million, a rise of 8.1% from the previous year. This increase is chiefly related to higher sales levels and also in part to selling price increases. Earnings before interest and tax (EBIT) improved by 1.4% in the period January- September 2008, to EUR 47.0 million. However, due to rapid price increases for raw materials, third quarter EBIT was lower than the comparable figure of the preceding year. Higher costs could only be partially passed on to customers, and with a time delay. Earnings before tax climbed by 12.0% above last year's level, to EUR 46.2 million, as a consequence of the improved financial result. Net profit for the period was up 5.1%, to EUR 31.4 million.
Performance of the divisions
The Sempermed division reported a 5.7% increase in revenue in the first nine months of 2008, to EUR 172.9 million. The improvement achieved in the third quarter is related, among other reasons, to selling price increases being made effective and the relatively strong US dollar, which had a positive effect due to the consolidation of Semperit's business in euros. Earnings before tax (EBT) of the Sempermed division improved by 24.8%, from EUR 9.1 million in the previous year to EUR 11.3 million in the first three quarters of 2008.
Growth of the Semperflex division slowed down in the first three quarters of 2008 as a response to global economic trends. On balance, total revenue rose by EUR 6.4 million, to EUR 129.4 million. Earnings before tax totalled 13.9 million, 13.3% below the previous year's level of EUR 16.1 million.
In the first nine months of 2008, total revenue of the Semperform division amounted to EUR 92.8 million, an increase of 8.1%. Earnings before tax fell by 3.4% year-on-year, to EUR 12.9 million (previous year: EUR 13.4 million).
The Sempertrans division posted strong growth in the first three quarters, with revenue climbing by 17.5%, to EUR 97.0 million. Earnings before tax rose by EUR 1.6 million, to EUR 10.4 million (previous year: EUR 8.8 million).
Outlook
A considerable decline in demand is expected in Europe and the USA in cyclical business areas. Significant losses in incoming orders have already been acknowledged in those segments that serve the construction and investment goods industries. However, the less cyclical business segment Sempermed has yet been unaffected.
end of announcement euro adhoc
Further inquiry note:
Semperit AG Holding
Mag. Sybille Bernhardt
Investor Relations
Tel.: +43 1 79 777- 210
mailto:sybille.bernhardt@semperit.at
Branche: Synthetics & Plastics
ISIN: AT0000785555
WKN: 870378
Index: WBI, ATX Prime, ViDX
Börsen: Börse Frankfurt / stock market
Börse Stuttgart / stock market
Börse Berlin / free trade
Wiener Börse AG / official market